Oct 29, 2026 12:00 PM
With Jaren Jackson Jr. sidelined and the frontcourt depth decimated, Utah faces a pivotal choice: panic-trade future assets or trust a depleted roster to survive November.
The Utah Jazz surrendered three first-round picks to acquire Jaren Jackson Jr. in February. Eight months later, the former Defensive Player of the Year has played seven regular-season games in Utah ... and another lengthy absence is underway.
This was supposed to be the season Jackson helped push the Jazz toward the postseason. Instead, they're 1-3, their frontcourt is depleted, and the pressure to find an immediate solution is only beginning.
Utah announced Tuesday that Jackson tore the MCL in his right knee during Monday's 110-105 loss to Memphis. He'll be reevaluated in six weeks, around December 8, though that isn't a guaranteed return date. Lauri Markkanen, who sprained his right wrist in the same game, is day-to-day.
Jusuf Nurkic remains sidelined with a foot injury, and Jaxson Hayes is dealing with a shoulder issue. Mo Bamba produced 14 points, seven rebounds and four blocks against Memphis, a welcome performance under the circumstances. But one promising night doesn't replace Jackson's presence for the next several weeks.
The temptation to trade for another big man makes sense.
The Jazz already sent Walker Kessler to the Lakers this summer in exchange for two unprotected first-round picks and two pick swaps. That deal added flexibility, but it also left Utah without another proven rim protector when injuries began piling up.
Spending meaningful draft capital to address that problem now would be a gamble ... especially when nobody knows how different this roster might look in a few weeks.
Earlier this month, The Salt Lake Tribune reported that Utah planned to stand pat rather than trade for a center while Nurkic recovered. Jackson's injury makes that stance tougher to defend, but it doesn't make patience unreasonable.
A low-cost veteran who can absorb minutes and help protect the paint? Worth exploring. Giving up another first-round pick to cover an uncertain stretch? That's a much harder sell.
Nurkic is due for reevaluation in early November. Jackson's comes around December 8, while December 15 opens trade eligibility for many players signed during the offseason. Utah can learn a great deal about its options before committing to another consequential move.
Of course, the schedule isn't cooperating.
The Jazz face San Antonio twice in their next three games, then road dates with New Orleans, Dallas and Minnesota. Their playoff hopes could take a hit before the frontcourt is healthy enough to make a fair assessment.
That's the challenge facing the front office. If losses pile up, calls for a trade will get louder — and every week without Jackson will make patience harder to justify.
But Utah invested heavily in Jackson because it believed he was worth building around. Seven games are hardly enough to determine whether that investment will deliver the results the franchise envisioned.
The Jazz can recover from a rough November. Another costly decision made out of desperation could set the franchise back far longer than Jackson's injury ever will.
Comments
Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy


